Browse by category

Researchers from the Netherlands and Yale School of Medicine - who evaluated sex differences in health status before and outcomes after metabolic and bariatric surgery (MBS) among men, premenopausal women, and postmenopausal women - have reported that men had more health conditions before MBS and lost less weight after surgery. Postmenopausal women showed a similar pattern but to a lesser extent. For the study, the researchers analysed data from the National Bariatric Surgery

In a new position paper, the American College of Physicians (ACP) has issued several recommendations on how policymakers can increase accessibility of obesity treatment for adults and address modifiable factors that contribute to obesity like diet and physical activity. The paper also includes further recommendations on reducing stigma associated with obesity, improving understanding of obesity among physicians and increasing access to healthy food. According to research from

A new approach to defining obesity could help physicians better determine which patients need more intensive treatment by focusing on the effects of excess adiposity on organs and tissues rather than relying primarily on whether a person meets a set of metabolic risk thresholds. Researchers from LSU's Pennington Biomedical Research Center examine the concept of "metabolically healthy obesity" and argue that a newer framework distinguishing preclinical obesity from clinical ob

Aqua Medical has announced the successful treatment of the first US patient in its FDA authorised Investigational Device Exemption (IDE) clinical trial evaluating the company's proprietary Proximal Intestinal Mucosal Ablation (PIMA) procedure for the treatment of type 2 diabetes. Aqua Medical is investigating a new diabetes procedure called proximal intestinal mucosal ablation (Illustration courtesy of Aqua Medical) Aqua Medical's investigational PIMA procedure utilises the c

Medtronic has presented its next-generation compute platform for the operating room. Touch Surgery Aide - an AI-native surgical computing platform that powers the Touch Surgery ecosystem - enables real-time artificial intelligence during procedures. Touch Surgery Aide was presented at the Society of Robotic Surgery (SRS) 2026 Annual Meeting in Florida. Touch Surgery Aide and the Touch Surgery ecosystem Built on years of experience, the Touch Surgery ecosystem brings insights

Johnson & Johnson has announced that the FDA has granted De Novo authorisation for its OTTAVA Robotic Surgical System, the world’s first table-integrated soft tissue robotic system. The system received marketing authorisation for multiple procedures in general surgery, including Roux-en-Y gastric bypass, gastrectomy, cholecystectomy, splenectomy, gastric sleeve, small bowel resection, appendectomy, lysis of adhesions, fundoplication and hiatal hernia repair. Johnson & Johnson

Young women are leading a worrying increase in early-onset type 2 diabetes (T2D) diagnoses in England, according to a new analysis led by researchers from Imperial College London, UK. In a population study of T2D in England, the researchers found a clear generational divide, with diagnosis rates rising rapidly among younger adults, particularly women, while declining in older age groups. The research, published in Lancet Regional Health Europe, is the first to examine trends

The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The British Medical Journal (BMJ) has reported. Although the absolute risk is low, awareness of this potential effect may help inform shared treatment decisions, according to the study’s researchers from the University of Pennsylvania, Philadelphia, PA. Alopecia has b

Two separate studies have report that GLP-1s are linked to fewer alcohol and substance related hospitalisations for people with alcohol or substance use dependence. In the first study, published in The Lancet Psychiatry, people with type 2 diabetes were hospitalised less frequently for alcohol or substance use disorders while undergoing treatment with GLP-1 receptor agonists, according to a large Swedish registry study involving the Central Institute of Mental Health (CIMH).

Adolescents and young adults in the US are increasingly using popular GLP-1 weight-loss drugs alone or in conjunction with metabolic and bariatric surgery (MBS) to manage obesity, according to a study by UT Southwestern Medical Center (UTSW) researchers. Severe obesity among adolescents and young adults has increased substantially over the past two decades, currently affecting about 9% of people ages 12 to 18. Among adults, the rate of severe obesity increased from 5% to 10%.